ADM Tronics Unlimited（ADMT）株式概要ADM Tronics Unlimited, Inc.は、その子会社を通じて、米国、オーストラリア、アジア、ヨーロッパにおいて、非侵襲的医療用エレクトロニクスおよびその他のアプリケーションの開発、製造、販売を行っている。 詳細ADMT ファンダメンタル分析スノーフレーク・スコア評価2/6将来の成長0/6過去の実績0/6財務の健全性5/6配当金0/6報酬当社が推定した公正価値より89.5%で取引されている 過去5年間の収益は年間22.7%増加しました。 リスク分析株式の流動性は非常に低い 意味のある時価総額がありません ( $5M )意味のある収益がありません ( $3M )すべてのリスクチェックを見るADMT Community Fair Values Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.Your Fair ValueUS$Current PriceUS$0.0782.7% 割高 内在価値ディスカウントGrowth estimate overAnnual revenue growth rate5 Yearstime period%/yrDecreaseIncreasePastFuture-1m5m2016201920222025202620282031Revenue US$3.4mEarnings US$319.0kAdvancedSet Fair ValueView all narrativesADM Tronics Unlimited, Inc. 競合他社Tantech HoldingsSymbol: NasdaqCM:TANHMarket cap: US$5.6mGreystone LogisticsSymbol: OTCPK:GLGIMarket cap: US$5.7mCN Energy GroupSymbol: NasdaqCM:CNEYMarket cap: US$9.7mOrigin MaterialsSymbol: NasdaqCM:ORGNMarket cap: US$8.3m価格と性能株価の高値、安値、推移の概要ADM Tronics Unlimited過去の株価現在の株価US$0.07852週高値US$0.1252週安値US$0.046ベータ0.111ヶ月の変化-6.27%3ヶ月変化-17.81%1年変化25.93%3年間の変化-21.92%5年間の変化-43.83%IPOからの変化-37.54%最新ニュースお知らせ • Aug 15ADM Tronics Unlimited, Inc. announced delayed 10-Q filingOn 08/14/2025, ADM Tronics Unlimited, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.お知らせ • Jul 02ADM Tronics Unlimited, Inc. announced delayed annual 10-K filingOn 06/30/2025, ADM Tronics Unlimited, Inc. announced that they will be unable to file their next 10-K by the deadline required by the SEC.お知らせ • Aug 15ADM Tronics Unlimited, Inc. announced delayed 10-Q filingOn 08/14/2024, ADM Tronics Unlimited, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.お知らせ • Jun 29ADM Tronics Unlimited, Inc. announced delayed annual 10-K filingOn 06/28/2024, ADM Tronics Unlimited, Inc. announced that they will be unable to file their next 10-K by the deadline required by the SEC.お知らせ • Feb 16ADM Tronics Unlimited, Inc. announced delayed 10-Q filingOn 02/15/2024, ADM Tronics Unlimited, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.お知らせ • Nov 29ADM Tronics Prepares for Commercial Launch of Vet-Sonotron(R) Veterinary Therapy DeviceADM Tronics announced its upcoming commercial launch of the Vet-Sonotron, non-invasive veterinary therapy device, for non-drug treatment of pain. This advancement is poised to reduce veterinary care by offering a non-invasive effective solution for a wide range of animal health conditions. Based on unprecedented performance of the Vet-SonotRON to treat pain without the use of drugs, the Company expects robust demand in a veterinary market estimated at over $64 billion in the United States. The Vet-Sonotron will be available for sale or lease as well as on a pay-per-treatment unit metering system developed by ADMT. The Vet-SonotRON represents a significant leap forward in veterinary medicine, harnessing state-of-the-art therapeutic technology to address painful and debilitating musculoskeletal ailments in companion animals and livestock. The device employs cutting-edge, non-invasive technology to stimulate tissue repair, reduce inflammation, and alleviate pain, while reducing the need for drugs or surgery. This innovative approach not only improves the overall well-being of animals but also minimizes stress for animals and their caregivers. ADMT's' commitment to scientific rigor and technological excellence is reflected in the Vet-Sonotron's development. Testing and research have demonstrated the device's effectiveness across multiple species, making it a versatile and indispensable tool for veterinary practitioners. The ease of use and customizable treatment options of the Vet-Sonoton further enhance its appeal, ensuring that veterinarians can tailor treatments to the unique needs of each animal.最新情報をもっと見るRecent updatesお知らせ • Aug 15ADM Tronics Unlimited, Inc. announced delayed 10-Q filingOn 08/14/2025, ADM Tronics Unlimited, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.お知らせ • Jul 02ADM Tronics Unlimited, Inc. announced delayed annual 10-K filingOn 06/30/2025, ADM Tronics Unlimited, Inc. announced that they will be unable to file their next 10-K by the deadline required by the SEC.お知らせ • Aug 15ADM Tronics Unlimited, Inc. announced delayed 10-Q filingOn 08/14/2024, ADM Tronics Unlimited, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.お知らせ • Jun 29ADM Tronics Unlimited, Inc. announced delayed annual 10-K filingOn 06/28/2024, ADM Tronics Unlimited, Inc. announced that they will be unable to file their next 10-K by the deadline required by the SEC.お知らせ • Feb 16ADM Tronics Unlimited, Inc. announced delayed 10-Q filingOn 02/15/2024, ADM Tronics Unlimited, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.お知らせ • Nov 29ADM Tronics Prepares for Commercial Launch of Vet-Sonotron(R) Veterinary Therapy DeviceADM Tronics announced its upcoming commercial launch of the Vet-Sonotron, non-invasive veterinary therapy device, for non-drug treatment of pain. This advancement is poised to reduce veterinary care by offering a non-invasive effective solution for a wide range of animal health conditions. Based on unprecedented performance of the Vet-SonotRON to treat pain without the use of drugs, the Company expects robust demand in a veterinary market estimated at over $64 billion in the United States. The Vet-Sonotron will be available for sale or lease as well as on a pay-per-treatment unit metering system developed by ADMT. The Vet-SonotRON represents a significant leap forward in veterinary medicine, harnessing state-of-the-art therapeutic technology to address painful and debilitating musculoskeletal ailments in companion animals and livestock. The device employs cutting-edge, non-invasive technology to stimulate tissue repair, reduce inflammation, and alleviate pain, while reducing the need for drugs or surgery. This innovative approach not only improves the overall well-being of animals but also minimizes stress for animals and their caregivers. ADMT's' commitment to scientific rigor and technological excellence is reflected in the Vet-Sonotron's development. Testing and research have demonstrated the device's effectiveness across multiple species, making it a versatile and indispensable tool for veterinary practitioners. The ease of use and customizable treatment options of the Vet-Sonoton further enhance its appeal, ensuring that veterinarians can tailor treatments to the unique needs of each animal.お知らせ • Jul 01ADM Tronics Unlimited, Inc. announced delayed annual 10-K filingOn 06/30/2023, ADM Tronics Unlimited, Inc. announced that they will be unable to file their next 10-K by the deadline required by the SEC.お知らせ • Feb 15ADM Tronics Unlimited, Inc. announced delayed 10-Q filingOn 02/14/2023, ADM Tronics Unlimited, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.お知らせ • Nov 15ADM Tronics Unlimited, Inc. announced delayed 10-Q filingOn 11/14/2022, ADM Tronics Unlimited, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.お知らせ • Aug 16ADM Tronics Unlimited, Inc. announced delayed 10-Q filingOn 08/15/2022, ADM Tronics Unlimited, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.お知らせ • Jun 30ADM Tronics Unlimited, Inc. announced delayed annual 10-K filingOn 06/29/2022, ADM Tronics Unlimited, Inc. announced that they will be unable to file their next 10-K by the deadline required by the SEC.お知らせ • Feb 15ADM Tronics Unlimited, Inc. announced delayed 10-Q filingOn 02/14/2022, ADM Tronics Unlimited, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.お知らせ • Aug 17ADM Tronics Unlimited, Inc. announced delayed 10-Q filingOn 08/16/2021, ADM Tronics Unlimited, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.お知らせ • Jun 30ADM Tronics Unlimited, Inc. announced delayed annual 10-K filingOn 06/29/2021, ADM Tronics Unlimited, Inc. announced that they will be unable to file their next 10-K by the deadline required by the SEC.お知らせ • Jan 20ADM Tronics Unlimited, Inc. Secures USPTO Registration for "Engineering Health"ADM Tronics Unlimited, Inc. has received Official Notice from the U.S. Patent and Trademark Office (USPTO) that its filing for protection for “Engineering Health” has been accepted, entitling the Company to use the registered trademark symbol in the U.S. for its engineering activities "in the field of Medical Devices.” This complements ADMT’s expansion of engineering development activities for its pipeline of proprietary therapeutic medical device technologies, as well as its medical device contract engineering services for customers. The USPTO registration of the Engineering Health registered service mark authorizes ADMT to use the “®” designation with the mark to identify such official registration. ADMT specializes in electronic medical device design, development and manufacturing of diagnostic and therapeutic medical technologies at its FDA-Registered Medical Device Manufacturing Facility in Northvale, NJ. ADMT has extensive experience in the development of all FDA classes of medical devices with a particular emphasis on electronic therapeutic modalities. The Company has a pipeline of several proprietary medical devices currently in various stages of development. In addition to its own medical technology developments, the Company is a one-stop source for complete design, engineering, regulatory and manufacturing services, specifically related to US and international medical device development. Its capability in bringing a medical device from the conceptual stage, through design, development and regulatory stages into production, all in-house, differentiates ADMT from firms supplying only portions of those services.お知らせ • Aug 15ADM Tronics Unlimited, Inc. announced delayed 10-Q filingOn 08/14/2020, ADM Tronics Unlimited, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.株主還元ADMTUS ChemicalsUS 市場7D-1.0%0.1%1.2%1Y25.9%8.9%28.7%株主還元を見る業界別リターン: ADMT過去 1 年間で8.9 % の収益を上げたUS Chemicals業界を上回りました。リターン対市場: ADMTは、過去 1 年間で28.7 % のリターンを上げたUS市場を下回りました。価格変動Is ADMT's price volatile compared to industry and market?ADMT volatilityADMT Average Weekly Movementn/aChemicals Industry Average Movement7.4%Market Average Movement7.2%10% most volatile stocks in US Market16.4%10% least volatile stocks in US Market3.1%安定した株価: ADMTの株価は、 US市場と比較して過去 3 か月間で変動しています。時間の経過による変動: 過去 1 年間のADMTのボラティリティの変化を判断するには データが不十分です。会社概要設立従業員CEO（最高経営責任者ウェブサイト1969n/aAndre' DiMinowww.admtronics.comADM Tronics Unlimited, Inc.は、子会社を通じて、米国、オーストラリア、アジア、ヨーロッパで、非侵襲的医療用エレクトロニクスおよびその他のアプリケーションの開発、製造、販売を行っている。ケミカル、エレクトロニクス、エンジニアリングの各セグメントを通じて事業を展開している。同社は、人間や動物の診断や治療に使用される独自のデバイスや、スパやホットタブ用の電子コントローラーを提供している。また、水性プライマーおよび接着剤、水性コーティング剤および樹脂、水性化学添加剤、帯電防止導電性塗料、コーティング剤、その他の製品を提供している。さらに、顎顔面補綴医療用途や、主に映画、テレビ、演劇などのプロフェッショナルメイク用途に使用される、水性、接着剤および関連する局所製剤を提供している。さらに、医療機器、エレクトロニクス、その他の技術や製品の設計、開発、製造のための研究、開発、規制、エンジニアリングサービス、医療電子治療技術も提供している。ADMトロニクス・アンリミテッド社は1969年に設立され、ニュージャージー州ノースベールに本社を置いている。もっと見るADM Tronics Unlimited, Inc. 基礎のまとめADM Tronics Unlimited の収益と売上を時価総額と比較するとどうか。ADMT 基礎統計学時価総額US$5.28m収益（TTM）-US$6.75k売上高(TTM)US$3.41m1.5xP/Sレシオ-781.4xPER（株価収益率ADMT は割高か？公正価値と評価分析を参照収益と収入最新の決算報告書（TTM）に基づく主な収益性統計ADMT 損益計算書（TTM）収益US$3.41m売上原価US$2.10m売上総利益US$1.32mその他の費用US$1.32m収益-US$6.75k直近の収益報告Dec 31, 2025次回決算日該当なし一株当たり利益（EPS）-0.0001グロス・マージン38.59%純利益率-0.20%有利子負債／自己資本比率66.4%ADMT の長期的なパフォーマンスは？過去の実績と比較を見るView Valuation企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/05/26 18:23終値2026/05/22 00:00収益2025/12/31年間収益2025/03/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレーク本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋ADM Tronics Unlimited, Inc. 0 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。0
お知らせ • Aug 15ADM Tronics Unlimited, Inc. announced delayed 10-Q filingOn 08/14/2025, ADM Tronics Unlimited, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.
お知らせ • Jul 02ADM Tronics Unlimited, Inc. announced delayed annual 10-K filingOn 06/30/2025, ADM Tronics Unlimited, Inc. announced that they will be unable to file their next 10-K by the deadline required by the SEC.
お知らせ • Aug 15ADM Tronics Unlimited, Inc. announced delayed 10-Q filingOn 08/14/2024, ADM Tronics Unlimited, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.
お知らせ • Jun 29ADM Tronics Unlimited, Inc. announced delayed annual 10-K filingOn 06/28/2024, ADM Tronics Unlimited, Inc. announced that they will be unable to file their next 10-K by the deadline required by the SEC.
お知らせ • Feb 16ADM Tronics Unlimited, Inc. announced delayed 10-Q filingOn 02/15/2024, ADM Tronics Unlimited, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.
お知らせ • Nov 29ADM Tronics Prepares for Commercial Launch of Vet-Sonotron(R) Veterinary Therapy DeviceADM Tronics announced its upcoming commercial launch of the Vet-Sonotron, non-invasive veterinary therapy device, for non-drug treatment of pain. This advancement is poised to reduce veterinary care by offering a non-invasive effective solution for a wide range of animal health conditions. Based on unprecedented performance of the Vet-SonotRON to treat pain without the use of drugs, the Company expects robust demand in a veterinary market estimated at over $64 billion in the United States. The Vet-Sonotron will be available for sale or lease as well as on a pay-per-treatment unit metering system developed by ADMT. The Vet-SonotRON represents a significant leap forward in veterinary medicine, harnessing state-of-the-art therapeutic technology to address painful and debilitating musculoskeletal ailments in companion animals and livestock. The device employs cutting-edge, non-invasive technology to stimulate tissue repair, reduce inflammation, and alleviate pain, while reducing the need for drugs or surgery. This innovative approach not only improves the overall well-being of animals but also minimizes stress for animals and their caregivers. ADMT's' commitment to scientific rigor and technological excellence is reflected in the Vet-Sonotron's development. Testing and research have demonstrated the device's effectiveness across multiple species, making it a versatile and indispensable tool for veterinary practitioners. The ease of use and customizable treatment options of the Vet-Sonoton further enhance its appeal, ensuring that veterinarians can tailor treatments to the unique needs of each animal.
お知らせ • Aug 15ADM Tronics Unlimited, Inc. announced delayed 10-Q filingOn 08/14/2025, ADM Tronics Unlimited, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.
お知らせ • Jul 02ADM Tronics Unlimited, Inc. announced delayed annual 10-K filingOn 06/30/2025, ADM Tronics Unlimited, Inc. announced that they will be unable to file their next 10-K by the deadline required by the SEC.
お知らせ • Aug 15ADM Tronics Unlimited, Inc. announced delayed 10-Q filingOn 08/14/2024, ADM Tronics Unlimited, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.
お知らせ • Jun 29ADM Tronics Unlimited, Inc. announced delayed annual 10-K filingOn 06/28/2024, ADM Tronics Unlimited, Inc. announced that they will be unable to file their next 10-K by the deadline required by the SEC.
お知らせ • Feb 16ADM Tronics Unlimited, Inc. announced delayed 10-Q filingOn 02/15/2024, ADM Tronics Unlimited, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.
お知らせ • Nov 29ADM Tronics Prepares for Commercial Launch of Vet-Sonotron(R) Veterinary Therapy DeviceADM Tronics announced its upcoming commercial launch of the Vet-Sonotron, non-invasive veterinary therapy device, for non-drug treatment of pain. This advancement is poised to reduce veterinary care by offering a non-invasive effective solution for a wide range of animal health conditions. Based on unprecedented performance of the Vet-SonotRON to treat pain without the use of drugs, the Company expects robust demand in a veterinary market estimated at over $64 billion in the United States. The Vet-Sonotron will be available for sale or lease as well as on a pay-per-treatment unit metering system developed by ADMT. The Vet-SonotRON represents a significant leap forward in veterinary medicine, harnessing state-of-the-art therapeutic technology to address painful and debilitating musculoskeletal ailments in companion animals and livestock. The device employs cutting-edge, non-invasive technology to stimulate tissue repair, reduce inflammation, and alleviate pain, while reducing the need for drugs or surgery. This innovative approach not only improves the overall well-being of animals but also minimizes stress for animals and their caregivers. ADMT's' commitment to scientific rigor and technological excellence is reflected in the Vet-Sonotron's development. Testing and research have demonstrated the device's effectiveness across multiple species, making it a versatile and indispensable tool for veterinary practitioners. The ease of use and customizable treatment options of the Vet-Sonoton further enhance its appeal, ensuring that veterinarians can tailor treatments to the unique needs of each animal.
お知らせ • Jul 01ADM Tronics Unlimited, Inc. announced delayed annual 10-K filingOn 06/30/2023, ADM Tronics Unlimited, Inc. announced that they will be unable to file their next 10-K by the deadline required by the SEC.
お知らせ • Feb 15ADM Tronics Unlimited, Inc. announced delayed 10-Q filingOn 02/14/2023, ADM Tronics Unlimited, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.
お知らせ • Nov 15ADM Tronics Unlimited, Inc. announced delayed 10-Q filingOn 11/14/2022, ADM Tronics Unlimited, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.
お知らせ • Aug 16ADM Tronics Unlimited, Inc. announced delayed 10-Q filingOn 08/15/2022, ADM Tronics Unlimited, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.
お知らせ • Jun 30ADM Tronics Unlimited, Inc. announced delayed annual 10-K filingOn 06/29/2022, ADM Tronics Unlimited, Inc. announced that they will be unable to file their next 10-K by the deadline required by the SEC.
お知らせ • Feb 15ADM Tronics Unlimited, Inc. announced delayed 10-Q filingOn 02/14/2022, ADM Tronics Unlimited, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.
お知らせ • Aug 17ADM Tronics Unlimited, Inc. announced delayed 10-Q filingOn 08/16/2021, ADM Tronics Unlimited, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.
お知らせ • Jun 30ADM Tronics Unlimited, Inc. announced delayed annual 10-K filingOn 06/29/2021, ADM Tronics Unlimited, Inc. announced that they will be unable to file their next 10-K by the deadline required by the SEC.
お知らせ • Jan 20ADM Tronics Unlimited, Inc. Secures USPTO Registration for "Engineering Health"ADM Tronics Unlimited, Inc. has received Official Notice from the U.S. Patent and Trademark Office (USPTO) that its filing for protection for “Engineering Health” has been accepted, entitling the Company to use the registered trademark symbol in the U.S. for its engineering activities "in the field of Medical Devices.” This complements ADMT’s expansion of engineering development activities for its pipeline of proprietary therapeutic medical device technologies, as well as its medical device contract engineering services for customers. The USPTO registration of the Engineering Health registered service mark authorizes ADMT to use the “®” designation with the mark to identify such official registration. ADMT specializes in electronic medical device design, development and manufacturing of diagnostic and therapeutic medical technologies at its FDA-Registered Medical Device Manufacturing Facility in Northvale, NJ. ADMT has extensive experience in the development of all FDA classes of medical devices with a particular emphasis on electronic therapeutic modalities. The Company has a pipeline of several proprietary medical devices currently in various stages of development. In addition to its own medical technology developments, the Company is a one-stop source for complete design, engineering, regulatory and manufacturing services, specifically related to US and international medical device development. Its capability in bringing a medical device from the conceptual stage, through design, development and regulatory stages into production, all in-house, differentiates ADMT from firms supplying only portions of those services.
お知らせ • Aug 15ADM Tronics Unlimited, Inc. announced delayed 10-Q filingOn 08/14/2020, ADM Tronics Unlimited, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.
